Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass
index≥ 30 kg· m− 2), daytime hypercapnia (arterial carbon dioxide tension≥ 45 mmHg) and …

Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Obesity-related respiratory disease reflects an increasing proportion of patients in both
inpatient and outpatient settings. It is important to recognize the impact of obesity on …

Non-invasive ventilation (NIV) is the mainstay to treat patients who need augmentation of
ventilation for acute and chronic forms of respiratory failure. The last several decades have …

Obstructive sleep apnea (OSA) is a known risk factor for cardiovascular disease in adults. It
is associated with incident systemic hypertension, arrhythmia, stroke, coronary artery …

Background Noninvasive ventilation (NIV) is an effective form of treatment in obesity
hypoventilation syndrome (OHS) with severe OSA. However, there is paucity of evidence in …

Subclinical abnormalities in cardiac and vascular structure reflect the adverse effects
triggered by a variety of risk factors on the cardiovascular (CV) system thereby representing …

Rationale: Obesity hypoventilation syndrome (OHS) has been associated with cardiac
dysfunction. However, randomized trials assessing the impact of long-term noninvasive …

This pre-eminent work has developed over six editions in response to man's attempts to
climb higher and higher unaided, and to spend more time at altitude for both work and …

Background Obstructive sleep apnoea (OSA) is the repetitive closure of the upper airway
during sleep. This results in disturbed sleep and excessive daytime sleepiness. It is a risk …